Marina Themoteo Varela

Ms. Marina Themoteo Varela

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2017 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
MVMarina Themoteo Varela
Marina Themoteo Varela
MLMarta L. Lima
Marta L. Lima
MGMariana K. Galuppo
Mariana K. Galuppo
ATAndré Tempone
André Tempone
AOAlberto De Oliveira
Alberto De Oliveira
JFJoão Paulo S. Fernandes
João Paulo S. Fernandes

1 February 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MVMarina Themoteo Varela
Marina Themoteo Varela
RDRoberto Z. Dias
Roberto Z. Dias
LMLigia F. Martins
Ligia F. Martins
DFDaiane D. Ferreira
Daiane D. Ferreira
ATAndré Tempone
André Tempone
JFJoão Paulo S. Fernandes
João Paulo S. Fernandes

1 October 2020 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
LOLidiane Oliveira
Lidiane Oliveira
MFMárcio Ferrarini
Márcio Ferrarini
ASAlexandre Paes dos Santos
Alexandre Paes dos Santos
MVMarina Themoteo Varela
Marina Themoteo Varela
ICIsabela Teresa Santos Corrêa
Isabela Teresa Santos Corrêa
RPRenata Pascon
Renata Pascon

16 February 2017 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
MCMichelle Fidelis Corrêa
Michelle Fidelis Corrêa
MVMarina Themoteo Varela
Marina Themoteo Varela
ABAleksandro Martins Balbino
Aleksandro Martins Balbino
ATAna Claudia Torrecilhas
Ana Claudia Torrecilhas
RLRichardt Gama Landgraf
Richardt Gama Landgraf
JFJoão Paulo Dos Santos Fernandes
João Paulo Dos Santos Fernandes

1 September 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MVMarina Themoteo Varela
Marina Themoteo Varela
MRMaiara M. Romaneli
Maiara M. Romaneli
MLMarta L. Lima
Marta L. Lima
SBSamanta Borborema
Samanta Borborema
ATAndré Tempone
André Tempone
JFJoão P.S. Fernandes
João P.S. Fernandes

24 April 2020 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MVMarina Themoteo Varela
Marina Themoteo Varela
JFJoão Paulo S. Fernandes
João Paulo S. Fernandes
Background: Neglected tropical diseases are a group of infections caused by microorganisms and viruses that affect mainly poor regions of the world. In addition, most available drugs are associated with long periods of treatment and high toxicity which limits the application and patient compliance. Investment in research and development is not seen as an attractive deal by the pharmaceutical industry since the final product must ideally be cheap, not returning the amount invested. Natural products have always been an important source for bioactive compounds and are advantageous over synthetic compounds when considering the unique structural variety and biological activities. On the other hand, isolation difficulties and low yields, environmental impact and high cost usually limit their application as drug per se. Objective: In this review, the use of natural products as prototypes for the semi-synthesis or total synthesis, as well as natural products as promising hits is covered, specifically regarding compounds with activities against trypanosomatids such as Trypanosoma spp. and Leishmania spp. Methods: Selected reports from literature with this approach were retrieved. Conclusion: As summary, it can be concluded that natural products are an underestimated source for designing novel agents against these parasites.